Alembic Pharmaceuticals Limited
APLLTD
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Jun 20261,868
Quarter ₹ crore YoY Mar 2024 1,475 +12.8% Jun 2024 1,476 +10.8% Sept 2024 1,580 +6.9% Dec 2024 1,406 -11.5% Jun 2025 1,494 +1.3% Sept 2025 1,796 +13.7% Dec 2025 1,642 +16.8% Mar 2026 1,719 — Jun 2026 1,868 +25.0% - ₹ crore
Jun 202614
Quarter ₹ crore Mar 2024 7 Jun 2024 3 Sept 2024 16 Dec 2024 15 Jun 2025 8 Sept 2025 11 Dec 2025 11 Mar 2026 26 Jun 2026 14 - ₹ crore
Jun 20261,882
Quarter ₹ crore Mar 2024 1,482 Jun 2024 1,479 Sept 2024 1,596 Dec 2024 1,422 Jun 2025 1,502 Sept 2025 1,808 Dec 2025 1,653 Mar 2026 1,745 Jun 2026 1,882 - Cost structure
- ₹ crore
Jun 2026416
Quarter ₹ crore Mar 2024 355 Jun 2024 357 Sept 2024 368 Dec 2024 369 Jun 2025 396 Sept 2025 408 Dec 2025 401 Mar 2026 407 Jun 2026 416 - ₹ crore
Jun 20261,626
Quarter ₹ crore Mar 2024 1,266 Jun 2024 1,266 Sept 2024 1,409 Dec 2024 1,318 Jun 2025 1,376 Sept 2025 1,591 Dec 2025 1,472 Mar 2026 1,546 Jun 2026 1,626 - Exceptional items and tax
- ₹ crore
Jun 2026256
Quarter ₹ crore Mar 2024 216 Jun 2024 213 Sept 2024 200 Dec 2024 104 Jun 2025 126 Sept 2025 216 Dec 2025 139 Mar 2026 173 Jun 2026 256 - ₹ crore
Jun 202659
Quarter ₹ crore Mar 2024 14 Jun 2024 37 Sept 2024 34 Dec 2024 18 Jun 2025 22 Sept 2025 37 Dec 2025 24 Mar 2026 -70 Jun 2026 59 - Profit
- ₹ crore
Jun 2026197
Quarter ₹ crore YoY Mar 2024 202 +54.6% Jun 2024 176 +80.7% Sept 2024 166 +23.9% Dec 2024 86 -63.2% Jun 2025 104 -41.2% Sept 2025 179 +8.2% Dec 2025 114 +33.4% Mar 2026 243 — Jun 2026 197 +90.3% - Per share
- ₹ per share
Jun 202610.02
Quarter ₹ per share Mar 2024 10.27 Jun 2024 8.96 Sept 2024 8.43 Dec 2024 4.37 Jun 2025 5.27 Sept 2025 9.12 Dec 2025 5.82 Mar 2026 12.37 Jun 2026 10.02 - Leverage
Debt to equity
timesJun 20260.00x
Quarter times Mar 2024 0.00x Jun 2024 0.00x Sept 2024 0.00x Dec 2024 0.00x Jun 2025 0.00x Sept 2025 0.00x Dec 2025 0.00x Mar 2026 0.00x Jun 2026 0.00x
| ₹ crore | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 1,475 | 1,476 | 1,580 | 1,406 | 1,494 | 1,796 | 1,642 | 1,719 | 1,868 | |
| Revenue YoY | +12.8% | +10.8% | +6.9% | -11.5% | +1.3% | +13.7% | +16.8% | — | +25.0% |
| 7 | 3 | 16 | 15 | 8 | 11 | 11 | 26 | 14 | |
| 1,482 | 1,479 | 1,596 | 1,422 | 1,502 | 1,808 | 1,653 | 1,745 | 1,882 | |
| Cost structure | |||||||||
| 355 | 357 | 368 | 369 | 396 | 408 | 401 | 407 | 416 | |
| 1,266 | 1,266 | 1,409 | 1,318 | 1,376 | 1,591 | 1,472 | 1,546 | 1,626 | |
| Exceptional items and tax | |||||||||
| 216 | 213 | 200 | 104 | 126 | 216 | 139 | 173 | 256 | |
| 14 | 37 | 34 | 18 | 22 | 37 | 24 | -70 | 59 | |
| Profit | |||||||||
| 202 | 176 | 166 | 86 | 104 | 179 | 114 | 243 | 197 | |
| Net profit YoY | +54.6% | +80.7% | +23.9% | -63.2% | -41.2% | +8.2% | +33.4% | — | +90.3% |
| Per share | |||||||||
| 10.27 | 8.96 | 8.43 | 4.37 | 5.27 | 9.12 | 5.82 | 12.37 | 10.02 | |
| Leverage | |||||||||
| Debt to equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.